MS vs IVZ
By Alex · Tickerpine
Morgan Stanley vs Invesco Ltd., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MS | IVZ |
|---|---|---|
| Price | $212.03 | $26.16 |
| Market cap | $334.43B | $11.60B |
| P/E ratio | 19.2 | — |
| ROE | 16.39% | -1.54% |
| Profit margin | 24.75% | -3.69% |
| Revenue growth | 16.30% | 14.10% |
| Dividend yield | 1.89% | 3.29% |
| Beta | 1.22 | 1.59 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MS vs IVZ in plain English
- MS is the bigger company — about 28.8× the market cap of IVZ.
- MS earns a higher return on equity (16% vs -2%).
- MS is growing revenue faster (16% vs 14%).
- IVZ has the higher dividend yield (3.29% vs 1.89%).
How would $1,000 have done in each?
MS return calculator
See what $1,000 in Morgan Stanley would be worth today.
IVZ return calculator
See what $1,000 in Invesco Ltd. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.